![PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas](https://www.oncoamericas.com/wp-content/uploads/2020/06/INGLES_GASTROINTESTINAL_First-line_FOLFOX_plus_panitumumab_PANDA_Noticias-Retangular.png)
PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas
![Frontiers | Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements Frontiers | Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements](https://www.frontiersin.org/files/Articles/1176950/fonc-13-1176950-HTML/image_m/fonc-13-1176950-g001.jpg)
Frontiers | Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
![Update on the management of elderly patients with colorectal cancer | Clinical and Translational Oncology Update on the management of elderly patients with colorectal cancer | Clinical and Translational Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12094-023-03243-0/MediaObjects/12094_2023_3243_Fig1_HTML.png)
Update on the management of elderly patients with colorectal cancer | Clinical and Translational Oncology
![Update on the management of elderly patients with colorectal cancer | Clinical and Translational Oncology Update on the management of elderly patients with colorectal cancer | Clinical and Translational Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12094-023-03243-0/MediaObjects/12094_2023_3243_Fig3_HTML.png)
Update on the management of elderly patients with colorectal cancer | Clinical and Translational Oncology
![Diseases | Free Full-Text | Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments Diseases | Free Full-Text | Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments](https://www.mdpi.com/diseases/diseases-11-00148/article_deploy/html/images/diseases-11-00148-g001.png)
Diseases | Free Full-Text | Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments
![Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. | Semantic Scholar Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7da083ce90bf4df8eecd9d8feffbdd53d2c67d52/6-Figure3-1.png)
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. | Semantic Scholar
![Cancers | Free Full-Text | Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study Cancers | Free Full-Text | Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study](https://pub.mdpi-res.com/cancers/cancers-14-05208/article_deploy/html/images/cancers-14-05208-g002.png?1666615897)
Cancers | Free Full-Text | Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study
![Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer—the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial | Trials | Full Text Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer—the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial | Trials | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13063-022-06883-9/MediaObjects/13063_2022_6883_Fig2_HTML.png)